Exact Sciences Corporation Website

Exact Sciences Corporation

NasdaqCM-EXAS

Basic

  • Market Cap

    $9,115.77M

  • EV

    $11.04B

  • Shares Out

    184.53M

  • Revenue

    $2,534.84M

  • Employees

    6,550

Margins

  • Gross

    73.67%

  • EBITDA

    -4.28%

  • Operating

    -12.59%

  • Pre-Tax

    -9.38%

  • Net

    -9.48%

  • FCF

    -0.81%

Returns (5Yr Avg)

  • ROA

    -9.84%

  • ROTA

    -38.87%

  • ROE

    -19.31%

  • ROCE

    -10.67%

  • ROIC

    -13.22%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $80.6

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $652.09M

  • Net Debt

    $1,922.65M

  • Debt/Equity

    0.82

  • EBIT/Interest

    -15.08

Growth (CAGR)

  • Rev 3Yr

    17.93%

  • Rev 5Yr

    36.95%

  • Rev 10Yr

    93.74%

  • Dil EPS 3Yr

    -33.94%

  • Dil EPS 5Yr

    -5.61%

  • Dil EPS 10Yr

    5.91%

  • Rev Fwd 2Yr

    13.39%

  • EBITDA Fwd 2Yr

    51.91%

  • EPS Fwd 2Yr

  • EPS LT Growth Est

    20%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

876.3

1,491.4

1,767.1

2,084.3

2,499.8

2,534.8

Total Revenues % Chg.

92.8%

70.2%

18.5%

17.9%

19.9%

15.2%

Cost of Goods Sold, Total

216.7

354.3

458.8

574.4

654.2

667.5

Gross Profit

659.6

1,137.1

1,308.3

1,509.9

1,845.5

1,867.4

Selling General & Admin Expenses, Total

737.6

1,071.3

1,538.3

1,639.9

1,638.3

1,655

R&D Expenses

139.7

554.1

385.6

393.4

425.9

441.1

Amortization of Goodwill and Intangible Assets

16

93.4

95

97.5

92.2

92.5

Other Operating Expenses

-2

-2

Other Operating Expenses, Total

893.4

1,718.8

2,018.9

2,130.8

2,154.4

2,186.6

Operating Income

-233.8

-581.7

-710.6

-620.9

-308.8

-319.3

Interest Expense, Total

-199.2

-67.9

-18.6

-19.6

-19.4

-21.2

Interest And Investment Income

26.5

6.6

31.8

32.7

38.4

Net Interest Expenses

-172.7

-61.4

13.2

-19.6

13.3

17.3

EBT, Excl. Unusual Items

-406.4

-643.1

-697.4

-640.5

-295.6

-302

Merger & Related Restructuring Charges

-117.7

Gain (Loss) On Sale Of Investments

-19.4

Gain (Loss) On Sale Of Assets

-13.2

Asset Writedown

-209.7

-20.2

-16

-0.6

-5

Other Unusual Items

23.7

-7.2

56.6

94.4

69.3

EBT, Incl. Unusual Items

-406.4

-829.1

-842.5

-632.6

-201.7

-237.7

Income Tax Expense

-193.4

-5.5

-246.9

-9.1

2.4

2.6

Earnings From Continuing Operations

-213.1

-823.6

-595.6

-623.5

-204.1

-240.2

Net Income

-213.1

-823.6

-595.6

-623.5

-204.1

-240.2

Net Income to Common Incl Extra Items

-213.1

-823.6

-595.6

-623.5

-204.1

-240.2

Net Income to Common Excl. Extra Items

-213.1

-823.6

-595.6

-623.5

-204.1

-240.2

Total Shares Outstanding

147.6

159.4

173.7

177.9

181.4

183.8

Weighted Avg. Shares Outstanding

131.3

151.1

171.3

176.4

180.1

181.1

Weighted Avg. Shares Outstanding Dil

131.3

151.1

171.3

176.4

180.1

181.1

EPS

-1.6

-5.4

-3.5

-3.5

-1.1

-1.3

EPS Diluted

-1.6

-5.4

-3.5

-3.5

-1.1

-1.3

EBITDA

-183.5

-418.3

-530.2

-423.4

-102.2

-108.4

Effective Tax Rate

47.6%

0.7%

29.3%

1.4%

-1.2%

-1.1%